Interleukin-10 does not affect phagocytosis of particulate antigen by bone marrow-derived dendritic cells but does impair antigen presentation

Immunology

Volumn 99, Issue 4, 2000, Pages 523-531

  Faulkner, L ^a   Buchan, G ^a   Baird, M ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; BCG VACCINE; CD86 ANTIGEN; GLYCOPROTEIN P 15095; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN; VACCINE;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL MATURATION; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DENDRITIC CELL; FLUORESCENCE; IMMUNE RESPONSE; IMMUNOTHERAPY; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; BCG VACCINE; BONE MARROW CELLS; CELLS, CULTURED; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; INTERLEUKIN-10; MICE; MICE, INBRED BALB C; PARTICLE SIZE; PHAGOCYTOSIS; RECOMBINANT PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 0034128791     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2000.00018.x     Document Type: Article

References (38)

1. 1. STEINMAN R.M. & SWANSON J. (1995) The endocytic activity of dendritic cells. J Exp Med 182, 283.
2. 2. SHEN Z., REZNIKOH G., DRANOFF G. & ROCK K.L. (1997) Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 158, 2723.
3. 3. SCHEICHER C., MEHLIG, M., DIENES H.P. & RESKE K. (1995) Uptake of microparticle-adsorbed protein antigen by bone marrow-derived dendritic cells results in up-regulation of interleukin-α and interleukin-12 p40/p35 and triggers prolonged, efficient antigen presentation. Eur J Immunol 25, 1566.
4. 4. AUSTYN J.M. (1996) New insights into the mobilization and phagocytic activity of dendritic cells. J Exp Med 183, 1287.
5. 5. SCHAKEL K., MAYER E., FEDERLE C., SCHMITZ M., RIETHMULLER G. & RIEBER E.P. (1998) A novel dendritic cell population in human blood: one-step immunomagnetic isolation by a specific mAb (M-DC8) and in vitro priming of cytotoxic T lymphocytes. Eur J Immunol 28, 4084.
6. 6. HENDERSON R.A., WATKINS S.C. & FLYNN J.L. (1997) Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J Immunol 159, 635.
7. 7. FILGUEIRA L., NESTLE F.O., RITTIG M., JOLLER H.I. & GROSCURTH P. (1996) Human dendritic cells phagocytose and process Borrelia burgdorferi. J Immunol 157, 2998.
8. 8. SU H., MESSER R., WHITMIRE W., FISCHER E., PORTIS J.C. & CALDWELL H.D. (1998) Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae. J Exp Med 188, 809.
9. 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 188, 1359.
10. 10. CELLA M., ENGERING A., PINET V., PIETERS J. & LANZAVECCHIA A. (1997) Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388, 782.
11. 11. PIERRE P., TURLEY S.J., GATH E., et al. (1997) Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388, 787.
12. 12. CAUX C., MASSACRIER C., VANBERVLIET B., et al. (1994) Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180, 1263.
13. 13. SPARWASSER T., KOCH E.S., VABULAS R.M., et al. (1998) Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur J Immunol 28, 2045.
14. 14. CELLA M., SALIO M., SAKAKIBARA Y., LANGEN H., JULKUNEN I. & LANZAVECCHIA A. (1999) Maturation, activation and protection of dendritic cells induced by double-stranded RNA. J Exp Med 189, 821.
15. 15. DE SMEDT T., VAN MECHELEN M., DE BECKER G., URBAIN J., LEO O. & MOSER M. (1997) Effect of interleukin-10 on dendritic cell maturation and function. Eur J Immunol 27, 1229.
16. 16. GEISSMANN F., REVY P., REGNAULT A., et al. (1999) TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J Immunol 162, 4567.
17. 17. MOREL A.S., QUARANTINO S., DOUEK D.C. & LONDEI M. (1997) Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of maturative step. Eur J Immunol 27, 26.
18. 18. INABA K., INABA, M., NAITO M. & STEINMAN R.M. (1993) Dendritic cell progenitor phagocytose particulates, including Bacillus Calmette Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J Exp Med 178, 479.
19. 19. DILLON S.M., HART D.N., ABERNETHY N., WATSON J.D. & BAIRD M.A. (1997) Priming to mycobacterial antigen in vivo using antigen-pulsed antigen presenting cells generated in vitro is influenced by the dose and presence of IL-4 in APC cultures. Scand J Immunol 46, 1.
20. 20. LABEUR M.S., ROTERS B., PERS B., et al. (1999) Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J Immunol 162, 168.
21. 21. WITMER-PACK M.D., OLIVIER W., VALINSKY J., SCHULER G. & STEINMAN R.M. (1987) Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J Exp Med 166, 1484.
22. 22. RESCIGNO M., GRANUCCI F., CITTERIO S., FOTI M. & RICCIARDI-CASTAGNOLI P. (1999) Coordinated events during bacteria-induced DC maturation. Immunol Today 20, 200.
23. 23. LUTZ M.B., KUKUTSCH N., OGILVIE A.L.J., et al. (1998) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Meth 223, 77.
24. 24. INABA K., TURLEY S., YAMAIDE F., et al. (1998) Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med 188, 2163.
25. 25. DEMANGEL C., BEAN A.G.D., MARTIN E., FENG C.G., KAMATH A.T. & BRITTON W.J. (1999) Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guèrin-infected dendritic cells. Eur J Immunol 29, 1972.
26. 26. STENGER S., NIAZI K.R. & MODLIN R.L. (1998) Down-regulation of CD1 on antigen-presenting cells by infection with Mycobacterium tuberculosis. J Immunol 161, 3582.
27. 27. VREMEC D. & SHORTMAN K. (1997) Dendritic cell subtypes in mouse lymphoid organs. J Immunol 159, 565.
28. 28. MACPHERSON G.G., FOSSUM S. & HARRISON B. (1989) Properties of lymph-borne (veiled) dendritic cells in culture. II. Expression of the IL-2 receptor: role of GM-CSF. Immunology 68, 108.
29. + cells. J Leukoc Biol 63, 620.
30. 30. KRONIN V., VREMEC D. & SHORTMAN K. (1997) Does the IL-2 receptor α chain induced on dendritic cells have a biological function? Int Immunol 10, 237.
31. 31. SVENSSON M., STOCKINGER B. & WICK M.J. (1997) Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells. J Immunol 158, 4229.
32. 32. OZAWA H., AIBA S., NAKAGAWA S. & TAGAMI H. (1996) Interferon-γ and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7) expression. Eur J Immunol 26, 648.
33. 33. FIORENTINO D.F., ZLOTNIK A., VIEIRA P., et al. (1991) IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146, 3444.
34. + T cells to secrete IL-4. Int Immunol 10, 1017.
35. 35. ENK A.H., ANGELONI V.L., UDEY M.C. & KATZ S.I. (1993) Inhibition of Langerhans cell antigen-presenting function by IL-10. J Immunol 151, 2390.
36. 36. STEINBRINK K., WOLFE M., JONULEH H., KNOP J. & ENK A.H. (1997) Induction of tolerance by IL-10-treated dendritic cells. J Immunol 159, 4772.
37. 37. FLEMING S.B., MCCAUGHAN C.A., ANDREWS A.E., NASH A.D. & MERCER A.A. (1997) A homolog of interleukin-10 is encoded by the poxvirus orf virus. J Virol 71, 4857.
38. 38. KANEGANE H., WAKIGUCHI H., KANEGANE C., KURASHIGE T. & TOSATO G. (1997) Viral interleukin-10 in chronic active Epstein-Barr virus infection. J Infect Dis 176, 254.